Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches

RT Borne, PD Varosy, FA Masoudi - JAMA internal medicine, 2013 - jamanetwork.com
Importance Implantable cardioverter-defibrillators (ICDs) have revolutionized the approach
to the prevention of sudden cardiac death and are commonly used in a wide range of high …

ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the …

GS Francis, BH Greenberg, DT Hsu, BE Jaski… - Journal of the American …, 2010 - jacc.org
Purpose...... 427 2 Pathways to Competence...... 427 2.1 Formal Training...... 427 2.2 ABIM
Certification...... 430 2.3 Alternative Pathways...... 430 2.3. 1 Pediatric Advanced HF and …

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the …

BL Wilkoff, BD Williamson, RS Stern, SL Moore… - Journal of the American …, 2008 - jacc.org
Objectives: Our purpose was to demonstrate that strategically chosen implantable
cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular fibrillation (VF) …

Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management

F Braunschweig, G Boriani, A Bauer, R Hatala… - Europace, 2010 - academic.oup.com
Background Almost 30 years after the first human implants, ICD therapy has become the
treatment of choice in patients at risk of developing malignant ventricular arrhythmias. 1, 2 …

[HTML][HTML] Factors associated with medication adherence among heart failure patients and their caregivers

B Aggarwal, A Pender, L Mosca… - Journal of nursing …, 2015 - ncbi.nlm.nih.gov
Background Reducing the rate of rehospitalization among heart failure patients is a major
public health challenge; medication non-adherence is a crucial factor shown to trigger …

Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock

JD Mishkin, SJ Saxonhouse, GW Woo… - Journal of the American …, 2009 - jacc.org
Multiple clinical trials support the use of implantable cardioverter-defibrillators (ICDs) for
prevention of sudden cardiac death in patients with heart failure (HF). Unfortunately, several …

Amiodarone in the COVID-19 era: treatment for symptomatic patients only, or drug to prevent infection?

F Sanchis-Gomar, CJ Lavie, DP Morin… - American Journal of …, 2020 - Springer
Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular
and supraventricular arrhythmias, has been identified as a candidate drug for use against …

Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death

JC Claro, R Candia, G Rada, F Baraona… - Cochrane Database …, 2015 - cochranelibrary.com
Background Sudden cardiac death (SCD) is one of the main causes of cardiac death. There
are two main strategies to prevent it: managing cardiovascular risk factors and reducing the …

Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators

I Battipaglia, L Barone, L Mariani, F Infusino… - Europace, 2010 - academic.oup.com
Aims Low left ventricular ejection fraction (LVEF) is the main indication of implantable
cardioverter defibrillators (ICD) in patients with dilated cardiomyopathy (DCM) for the …

Performance of an ICD algorithm to detect lead noise and reduce inappropriate shocks

S Beau, S Greer, CR Ellis, J Keeney, S Asopa… - Journal of Interventional …, 2016 - Springer
Background Implantable cardioverter-defibrillators (ICD) provide treatment for life-
threatening ventricular tachyarrhythmias. Failure of the pace/sense conductor of an ICD lead …